Summary of Significant Accounting Policies (Details)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2020 USD ($)	Jun. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2020 USD ($)	Dec. 31, 2020 USD ($)	Jun. 30, 2021 AUD ($)	Dec. 31, 2020 AUD ($)
Accounting Policies [Abstract]
Cash	$ 176,188		$ 176,188		$ 165,092	$ 234,930	$ 214,240
Property and equipment	1,613,000		1,613,000		1,103,000
Research and development	1,850		26,165
Due from related parties	26,850		26,850		0
Deferred research grant revenue			$ 25,000		$ 24,315
Research and development tax percentage			43.50%		43.50%
Research and development tax incentive	932,057		$ 932,057		$ 0
Other income	441,546		672,824
Research and development expense	$ 516,407		$ 516,407
Basic weighted average shares outstanding (in Shares) | shares	400,000		400,000
Aggregate exercise price (in Dollars per share) | $ / shares	$ 0.01		$ 0.01